These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 6321840

  • 1. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL, Tagliabue A, Ames RE, Teramoto YA, Cannon GB, Alford C, Herberman RB, Schlom J.
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [Abstract] [Full Text] [Related]

  • 2. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease.
    Cannon GB, Barsky SH, Alford TC, Jerome LF, Tinley V, McCoy JL, Dean JH.
    J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226
    [Abstract] [Full Text] [Related]

  • 3. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O.
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [Abstract] [Full Text] [Related]

  • 4. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M, Wanebo HJ, Tsuei L, Ashikari R, Sarkar NH.
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [Abstract] [Full Text] [Related]

  • 5. Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
    Blair PB, Lane MA, Yagi MJ.
    J Immunol; 1975 Jul; 115(1):190-4. PubMed ID: 50346
    [Abstract] [Full Text] [Related]

  • 6. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
    Blair PB, Lane MA.
    J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
    [Abstract] [Full Text] [Related]

  • 7. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
    Blair PB, Lane MA, Mar P.
    J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
    Black MM, Zachrau RE, Dion AS, Shore B, Fine DL, Leis HP, Williams CJ.
    Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of cellular immune response to cancer of the breast.
    Herberman RB.
    Ann Clin Lab Sci; 1979 Nov; 9(6):467-73. PubMed ID: 229763
    [Abstract] [Full Text] [Related]

  • 13. Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice.
    Gillette RW, Lowery LT.
    Cancer Res; 1976 Nov; 36(11 Pt 1):4008-14. PubMed ID: 184922
    [Abstract] [Full Text] [Related]

  • 14. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM, Zachrau RE.
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of mammary tumor cultures from four mouse strains infected with mammary tumor virus.
    Yagi MJ.
    Cancer Res; 1975 Feb; 35(2):370-3. PubMed ID: 162873
    [Abstract] [Full Text] [Related]

  • 16. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB, Dyer CA, Mortensen RF.
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract] [Full Text] [Related]

  • 17. In vitro immune responses to viral and tumor antigens in murine breast cancer.
    Sigel MM, Lopez DM, Ortiz-Muniz G.
    Cancer Res; 1976 Feb; 36(2 pt 2):748-52. PubMed ID: 1253159
    [Abstract] [Full Text] [Related]

  • 18. Implications of humoral antibody in mice and humans to breast tumor and mouse mammary tumor virus-associated antigens.
    Bowen JM, Dmochowski L, Miller MF, Priori ES, Seman G, Dodson ML, Maruyama K.
    Cancer Res; 1976 Feb; 36(2 pt 2):759-64. PubMed ID: 175935
    [Abstract] [Full Text] [Related]

  • 19. Natural immunity in the oncornavirus-infected mouse.
    Blair PB.
    Cancer Res; 1976 Feb; 36(2 pt 2):734-8. PubMed ID: 175933
    [Abstract] [Full Text] [Related]

  • 20. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
    Black MM, Zachrau RE, Shore B, Dion AS, Leis HP.
    Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.